This contrasts with our previous report of a CR achieved with single-agent obatoclax (20 mg/m2 over 24 hours) in one older treatment-naive patient with AML with a mixed-lineage leukemia (MLL) t(9;11) translocation [14]. This evidence concerns the gene KMT2A and acute myeloid leukemia.